Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis
Alcohol, Clinical and Experimental Research · 2026-11 · 50 (11)
DOI: 10.1111/acer.70397 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 09.11.2026. Verfasst von Omar Albhaisi und 49 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmo…. Hauptthemen laut MEDLINE: Hepatitis, Alcoholic, Substance-Related Disorders. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, U.S. Department of Health and Human Services, NIAAA NIH HHS.
Abstract (Originalsprache)
Background and Aims Alcohol‐associated hepatitis (AH) carries high short‐term mortality. Although concomitant substance use is common in patients with AH, its impact on clinical outcomes remains unclear. We aimed to determine the prevalence of active substance use and evaluate its association with clinical outcomes in a large, multinational cohort of hospitalized patients with AH.
Methods
We conducted a prospective, multicenter study across 38 centers in 13 countries (2015–2024). Adults meeting National Institute on Alcohol Abuse and Alcoholism (NIAAA) criteria for AH were enrolled. The primary outcome was all‐cause mortality stratified by substance use. Fine–Gray subdistribution hazard models were used to identify mortality predictors, with liver transplantation (LT) treated as a competing event.
Results
We included 814 patients, with a mean age of 49.5 ± 10.6 years, and 88.8% were male. Active cannabis and cocaine use were reported in 6.1% and 5.5%, respectively. Over follow‐up, 210 patients (25.8%) died, and 35 (4.3%) underwent LT. In multivariable analysis, active cannabis use independently predicted higher mortality (sHR 2.49, 95% CI 1.52–4.09; p < 0.001), along with higher MELD scores and ACLF grades 2–3. Corticosteroid therapy (sHR 0.57, 95% CI 0.38–0.85; p = 0.007) and higher educational levels (sHR 0.34 and 0.31 for intermediate and highest categories, respectively) were associated with improved survival.
Conclusions
Active substance use—particularly cannabis use—was independently associated with increased mortality in patients hospitalized with AH, even after adjusting for liver disease severity and accounting for transplantation as a competing event. These findings identify a behavioral dimension of AH severity and highlight the need to integrate addiction medicine and psychiatric care into hepatology practice to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
- Department of Medicine, Division of Gastroenterology, Western University, London Health Sciences Center, London, Ontario, Canada.
- Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Observatorio Multicéntrico de Enfermedades Gastrointestinales (OMEGA), Santiago, Chile.
- Division of Liver Disease & Transplant Hepatology, New Jersey Medical School, Newark, New Jersey, USA.
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, Brazil.
ORCID-Profile: Omar Albhaisi, Francisco Idalsoaga, Wei Wang, Roberta C Araujo, Guilherme Massote Fontanini, Arun Valsan, Gowripriya Nair, Bastián Alcayaga, Jorge Arnold, María Ayala-Valverde, Carolina Ramirez-Cadiz, Hanna Blaney, Vinay Jahagirdar, Hyundam Gu, S Fisher Rhoads, Ximena Parraga, Butros Fakhoury, Prasun K Jalal, Mohamad Ali Ibrahim, Mohamad A Elfeki, Juan Pablo Roblero, Daniela Simian, José Antonio Velarde-Ruiz Velasco, Jacqueline Córdova, Fátima Higuera-de-la-Tijera, Rita Silva, Cristina Melo Rocha, Gustavo Henrique Pereira, Fernando Bessone, Ayelen Kisch, Manuel Mendizabal, Sebastián Marciano, Gonzalo Gomez Perdiguero, Pedro Montes, Patricia Guerra Salazar, Geraldine Ramos, Enrique Carrera, Lamia Haque, Kristina R Chacko, Lubomir Skladaný, Arun J Sanyal, Vijay H Shah, Patrick S Kamath, Marco Arrese, Winston Dunn, Ashwani K Singal, Ramon Bataller, Luis Antonio Díaz, Juan Pablo Arab
Förderung
- NIGMS NIH HHS
- U.S. Department of Health and Human Services
- NIAAA NIH HHS
- Fondo Nacional de Desarrollo Científico y Tecnológico
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of General Medical Sciences
Zitieren
APA
Albhaisi, O., Idalsoaga, F., Wang, W., Araujo, R. C., Fontanini, G. M., Valsan, A., Nair, G., Alcayaga, B., Arnold, J., Ayala-Valverde, M., Ramirez-Cadiz, C., Blaney, H., Jahagirdar, V., Gu, H., Rhoads, S. F., Parraga, X., Fakhoury, B., Jalal, P. K., Ibrahim, M. A., …, & Arab, J. P. (2026). Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis. Alcohol, Clinical and Experimental Research, 50(11). https://doi.org/10.1111/acer.70397
Vancouver
Albhaisi O, Idalsoaga F, Wang W, Araujo RC, Fontanini GM, Valsan A, et al. Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis. Alcohol, Clinical and Experimental Research. 2026;50(11). doi:10.1111/acer.70397
BibTeX
@article{Albhaisi2026,
author = {Albhaisi, Omar and Idalsoaga, Francisco and Wang, Wei and Araujo, Roberta C and Fontanini, Guilherme Massote and Valsan, Arun and Nair, Gowripriya and Alcayaga, Bastián and Arnold, Jorge and Ayala-Valverde, María and Ramirez-Cadiz, Carolina and Blaney, Hanna and Jahagirdar, Vinay and Gu, Hyundam and Rhoads, S Fisher and Parraga, Ximena and Fakhoury, Butros and Jalal, Prasun K and Ibrahim, Mohamad Ali and Elfeki, Mohamad A and Roblero, Juan Pablo and Simian, Daniela and Velasco, José Antonio Velarde-Ruiz and Córdova, Jacqueline and Higuera-de-la-Tijera, Fátima and Silva, Rita and Rocha, Cristina Melo and Pereira, Gustavo Henrique and Bessone, Fernando and Tanno, Mario and Kisch, Ayelen and Mendizabal, Manuel and Marciano, Sebastián and Perdiguero, Gonzalo Gomez and Montes, Pedro and Salazar, Patricia Guerra and Ramos, Geraldine and Carrera, Enrique and Haque, Lamia and Chacko, Kristina R and Skladaný, Lubomir and Sanyal, Arun J and Shah, Vijay H and Kamath, Patrick S and Arrese, Marco and Dunn, Winston and Singal, Ashwani K and Bataller, Ramon and Díaz, Luis Antonio and Arab, Juan Pablo},
title = {Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
volume = {50},
number = {11},
doi = {10.1111/acer.70397}
}
EUVIMED